Literature Highlights - July 2022
cytokines; inflammation; systemic lupus erythematosus; autoimmune diseases; biological therapy; glucocorticoids; hydroxychloroquine; lupus nephritis; outcome assessment, health care; tapering; personalised decision-making; outcomes; discontinuation; B cell depletion, rituximab, SLE, LN, obinutuzumab